Brought to you by 
Entelos closes $20mm IPO
04 May 2006
Executive Summary
US-based Entelos Inc., a biotech specializing in computer-generated, or in silico, laboratory technology, sold £11.4mm ($20mm) of stock in its initial public offering on the London Stock Exchange's AIM. It sold 13.8mm shares at 82.75 pence each.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- ADMET
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com